Fmoc-D-HLeu-OH

Fmoc-D-HLeu-OH is a D-stereochemical, Fmoc-protected leucine derivative in which the α-amino group is masked as the base-labile fluorenylmethoxycarbonyl (Fmoc) carbamate while the α-carboxylic acid remains available for peptide bond formation. The molecule therefore combines a chiral, branched aliphatic side chain characteristic of homologue leucine chemistry with a protected amine handle compatible with solid-phase or solution-phase coupling workflows. The Fmoc group provides orthogonal protection during assembly and can be removed under standard base conditions to regenerate the free amine for sequential peptide elongation. The presence of a free carboxylic acid enables conversion into activated esters or coupling-ready derivatives, supporting downstream synthesis of D-configured peptide segments and chiral amino acid intermediates.

1. Peptide Synthesis

Fmoc-D-HLeu-OH is used in peptide synthesis workflows where D-amino acid incorporation is required to control stereochemistry, proteolytic stability, and conformational preferences. The Fmoc-protected amine supports stepwise peptide coupling after deprotection, while the terminal carboxylic acid participates in amide bond formation using common peptide coupling chemistries. The D configuration at the α-carbon enables construction of stereochemically defined sequences for peptide building block preparation, including D-residue-containing fragments used to probe backbone recognition. Downstream, D-HLeu-containing peptides can be extended, cyclized, or functionalized to generate research-grade peptide analogs and stereodefined materials.

2. Peptidomimetics Development

Fmoc-D-HLeu-OH is suitable for peptidomimetic construction in chemical biology and medicinal chemistry research settings focused on backbone modification. The protected amino acid architecture allows incorporation of a D-configured hydrophobic residue into peptide-like scaffolds, supporting systematic variation of steric and stereoelectronic features. The Fmoc group enables controlled assembly of analogs, while the free carboxyl functionality supports further derivatization such as terminal amidation or conversion to carboxylate-bearing motifs. The resulting D-residue-containing peptidomimetics can serve as molecular scaffolds for structure-activity relationship studies and for generating stereochemically constrained analog libraries.

3. Protein Engineering

Fmoc-D-HLeu-OH can be applied to protein engineering and enzyme-related research where D-amino acid residues are introduced to modulate stability, folding behavior, or substrate recognition. The D-amino acid stereocenter provides a defined inversion relative to L-residue counterparts, enabling design of protein segments or peptide domains with altered backbone geometry. Fmoc protection supports reliable synthesis of D-HLeu-containing peptides that can be used as ligands, domains, or building blocks for further conjugation to biomacromolecules. Downstream utilization includes preparation of stereodefined protein-interaction probes and engineered biomolecule fragments for mechanistic studies.

4. Chemical Biology Probes

Fmoc-D-HLeu-OH is used in chemical biology for constructing D-amino acid-containing probes that probe binding interfaces and biomolecular recognition. The Fmoc-protected amine and carboxylic acid enable sequential synthesis of labeled or functionalized peptide constructs, including incorporation into affinity tags, imaging probes, or mechanistic inhibitors. The hydrophobic side chain supports interaction-driven positioning within binding pockets, while D stereochemistry can tune resistance to enzymatic degradation during assay timelines. The synthesized D-HLeu-containing probes can then be used as intermediates for biomolecule labeling strategies and for generating stereochemically defined interaction reagents.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-D-HLeu-OH is applicable to pharmaceutical manufacturing and fine chemical synthesis as a protected amino acid intermediate for producing D-configured peptide fragments used in drug discovery pipelines and process development. The Fmoc carbamate protection strategy supports controlled deprotection and coupling steps, which aligns with scalable peptide synthesis operations in both solution-phase and solid-phase manufacturing contexts. The free carboxylic acid enables conversion into activated coupling forms or direct incorporation into longer sequences during intermediate preparation. Downstream, D-HLeu-containing peptide intermediates can be carried into further transformations such as terminal functional group adjustments, conjugation steps, or formulation-relevant derivative generation for industrial chemical production.

1. Emu oil in combination with other active ingredients for treating skin imperfections

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Myotropic activity of allatostatins in tenebrionid beetles